What is it about?
Anti-cancer drugs are very limited access to reach cancer cell because of various physical-chemical drawbacks of API and biological factors. So that bio-compatible and biodegradable polymers have promoted address the cancer cell by loading of drug
Featured Image
Why is it important?
Recent global updates indicate a daily increase in the number of people affected by cancer, underscoring the urgent need for advancements in cancer research, particularly in developing effective drug delivery systems. Conventional treatment strategies for hepatocellular carcinoma (HCC) face several limitations, including low aqueous solubility, high drug doses, non-specific targeting of HCC cells, and associated toxicity or side effects. Biodegradable polymer-based nanomedicines present a promising approach to enhance drug uptake by HCC cells. These nanomedicines can prolong drug circulation in the blood, increase retention time, and release the drug specifically at the target site. This review summarizes recent advancements in the design of polymeric nanocarriers for HCC, aiming to overcome the persistent challenges associated with traditional HCC chemotherapy. The various strategies discussed herein provide valuable insights for developing and formulating effective nanomedicine-based treatments for hepatocellular carcinoma.
Perspectives
Read the Original
This page is a summary of: Polymeric nanoparticles based treatment approaches for hepatocellular carcinoma (HCC), January 2023, American Institute of Physics,
DOI: 10.1063/5.0168936.
You can read the full text:
Resources
Contributors
The following have contributed to this page